SE

Evy Lundgren Akerlund

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Evy Lundgren Akerlund. Retrieved from https://idiyas.com/inventor/evy-lundgren-akerlund-uhswkx42

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
 

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Evy Lundgren Akerlund: Innovator in Bone and Cartilage Treatment

Introduction

Evy Lundgren Akerlund is a notable inventor based in Sweden. She has made significant contributions to the field of medical science, particularly in the prevention and treatment of bone and cartilage damage. Her innovative work focuses on utilizing mesenchymal stem cells for therapeutic purposes.

Latest Patents

Evy Lundgren Akerlund holds a patent titled "Prevention And Treatment Of Bone And Cartilage Damage Or Disease." This patent discloses compositions and methods for the prevention and/or treatment of conditions involving disease or damage in mammalian cartilage and bone. The innovative approach involves using mesenchymal stem cells isolated with anti-integrin a10 antibodies.

Career Highlights

Evy is currently associated with Xintela AB, a company dedicated to advancing medical treatments. Her work at Xintela AB emphasizes the importance of stem cell research in regenerative medicine. Despite having no patents listed under her name, her contributions to the field are noteworthy.

Collaborations

Evy collaborates with esteemed colleagues, including Christina Uvebrant and Jan Talts. These partnerships enhance the research and development efforts at Xintela AB, fostering innovation in medical treatments.

Conclusion

Evy Lundgren Akerlund is a pioneering inventor whose work in bone and cartilage treatment showcases the potential of stem cell therapy. Her dedication to advancing medical science is evident through her innovative research and collaborations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…